• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tevogen Bio Inc

< Previous 1 2 3 4 5 Next >
News headline image
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
March 11, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 09, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
March 06, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
March 05, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Announces Reverse Stock Split
March 04, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
February 27, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
January 30, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
January 29, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
January 12, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
December 22, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
December 11, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine
December 09, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
November 14, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID
November 05, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
November 03, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
October 29, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest
October 15, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
September 25, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
September 23, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
September 19, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
September 10, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
News headline image
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
September 09, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap